Literature DB >> 23430950

Successful weight loss in two adult patients diagnosed with late-onset long-chain Fatty Acid oxidation defect.

H Zweers1, C Timmer, E Rasmussen, M den Heijer, H de Valk.   

Abstract

UNLABELLED: Patients with long-chain fatty acid oxidation defect (LCFAOD) cannot tolerate fasting and are restricted in their physical activity, hence their increased risk of obesity. Experts therefore advise avoidance of catabolic situations and discourage weight reduction in these patients.Two patients with late-diagnosed LCFAOD undergoing treatment at two academic centers successfully lost weight under supervision of a metabolic dietitian. Patient 1 (male, 47 years) diagnosed with CPT 2 deficiency lost 10 kg body weight in a 3-month period with the help of an energy and LCT-restricted, MCT- and carbohydrate-rich diet in combination with an exercise program. CK levels, C16, C18, and C18:1 levels of his acylcarnitine profile and his blood pressure decreased during the period of weight reduction. Patient 2 (male, 39 years) has a VLCAD deficiency. Dietary advice was energy and LCT restriction, MCT and carbohydrate-enriched food with raw cornstarch added during the night. Patient 2 lost almost 40 kg body weight to 87.6 kg (BMI 25.1) in 2 years. CK, insulin, TG, and ALAT blood levels decreased.
CONCLUSION: Weight reduction without loss of metabolic control seems possible in late-onset LCFAOD patients. No metabolic crisis occurred in these two patients, while the positive effects of weight reduction were clear. The residual enzyme function in late-onset LCFAOD may be one of the reasons that metabolic decompensation was prevented. In addition, dietary adjustments to prevent excessive fatty acid oxidation likely contributed as well. Therefore, expert supervision by a dietician specialized in metabolic diseases is recommended. Concise SentenceContrary to the current literature, weight loss in patients with late-diagnosed LCFAOD can be successful. A description of two FOAD patients who lost weight without encountering negative side effects at two academic centers is given.

Entities:  

Year:  2012        PMID: 23430950      PMCID: PMC3565639          DOI: 10.1007/8904_2012_131

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  6 in total

1.  Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop.

Authors:  U Spiekerkoetter; M Lindner; R Santer; M Grotzke; M R Baumgartner; H Boehles; A Das; C Haase; J B Hennermann; D Karall; H de Klerk; I Knerr; H G Koch; B Plecko; W Röschinger; K O Schwab; D Scheible; F A Wijburg; J Zschocke; E Mayatepek; U Wendel
Journal:  J Inherit Metab Dis       Date:  2009-04-28       Impact factor: 4.982

2.  Substrate oxidation and cardiac performance during exercise in disorders of long chain fatty acid oxidation.

Authors:  Annie M Behrend; Cary O Harding; James D Shoemaker; Dietrich Matern; David J Sahn; Diane L Elliot; Melanie B Gillingham
Journal:  Mol Genet Metab       Date:  2011-10-01       Impact factor: 4.797

3.  Effects of higher dietary protein intake on energy balance and metabolic control in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency.

Authors:  Melanie B Gillingham; Jonathan Q Purnell; Julia Jordan; Diane Stadler; Andrea M Haqq; Cary O Harding
Journal:  Mol Genet Metab       Date:  2006-09-22       Impact factor: 4.797

Review 4.  Current issues regarding treatment of mitochondrial fatty acid oxidation disorders.

Authors:  Ute Spiekerkoetter; Jean Bastin; Melanie Gillingham; Andrew Morris; Frits Wijburg; Bridget Wilcken
Journal:  J Inherit Metab Dis       Date:  2010-09-10       Impact factor: 4.982

Review 5.  Disorders of muscle lipid metabolism: diagnostic and therapeutic challenges.

Authors:  Pascal Laforêt; Christine Vianey-Saban
Journal:  Neuromuscul Disord       Date:  2010-08-05       Impact factor: 4.296

6.  The Harris Benedict equation reevaluated: resting energy requirements and the body cell mass.

Authors:  A M Roza; H M Shizgal
Journal:  Am J Clin Nutr       Date:  1984-07       Impact factor: 7.045

  6 in total
  2 in total

1.  Dietary restriction in the long-chain acyl-CoA dehydrogenase knockout mouse.

Authors:  Eugène F Diekman; Michel van Weeghel; Mayte Suárez-Fariñas; Carmen Argmann; Pablo Ranea-Robles; Ronald J A Wanders; Gepke Visser; Ingeborg van der Made; Esther E Creemers; Sander M Houten
Journal:  Mol Genet Metab Rep       Date:  2021-03-30

Review 2.  Clinical manifestations and management of fatty acid oxidation disorders.

Authors:  J Lawrence Merritt; Erin MacLeod; Agnieszka Jurecka; Bryan Hainline
Journal:  Rev Endocr Metab Disord       Date:  2020-12       Impact factor: 6.514

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.